hey Luke, they just need to produce..I heard this clinical data BS for too long...$55 million in cash...procedure a 75% loss in share price and burnt close $27m already on a land & lab that merchant wants to offload...nice work and now onto a 3rd CEO...not haters just pissed off investors...